NCT07538102

Brief Summary

This study aims to evaluate the effect of respiratory physiotherapy on diaphragm thickness in patients receiving mechanical ventilation support in the intensive care unit. Thinning and dysfunction of the diaphragm muscle observed during mechanical ventilation complicate the extubation process and increase the risk of respiratory failure in patients. Diaphragm dysfunction prolongs ventilator use and increases ICU mortality. The main objective of this research is to determine whether respiratory physiotherapy has protective or ameliorative effects on diaphragm muscle structure and function, to optimize the ventilator weaning process, and to provide scientific contributions to the field of respiratory rehabilitation. Changes in diaphragm thickness will be objectively evaluated using ultrasonography, and the aim is to obtain evidence-based data on the effectiveness of respiratory physiotherapy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Aug 2025Oct 2026

Study Start

First participant enrolled

August 1, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 13, 2026

Last Update Submit

April 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Diaphragm Thickness

    Diaphragm thickness measured by ultrasonography (high-frequency linear probe, 5-15 MHz) at the right midaxillary line between the 8th and 9th ribs in the transverse plane, at end-inspiration and end-expiration. Diaphragm Thickening Fraction (DTF) calculated as: DTF (%) = \[(Inspiratory Thickness - Expiratory Thickness) / Expiratory Thickness\] × 100

    Baseline (start of mechanical ventilation), Day 5, Day 7, or discharge day (whichever comes first)

Study Arms (2)

Group A

Standard ICU physiotherapy will be applied once daily for 15-20 minutes.

Other: Standard ICU Physiotherapy

Group B

In addition to standard ICU physiotherapy once daily for 15-20 minutes, neuromuscular electrical stimulation (NMES) will be applied to the diaphragmatic region twice daily.

Device: Neuromuscular Electrical Stimulation (NMES)

Interventions

Standard ICU physiotherapy applied once daily for 15-20 minutes.

Group A

NMES applied to the diaphragmatic region twice daily, in addition to standard ICU physiotherapy.

Group B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients receiving invasive mechanical ventilation in the Anesthesia Intensive Care Unit of Hitit University Faculty of Medicine, Erol Olçok Training and Research Hospital, who meet the inclusion criteria and whose legal representatives have provided informed consent.

You may qualify if:

  • Age ≥ 18 years
  • Mechanically ventilated for at least 5 days
  • Hemodynamically stable
  • Unconscious (Glasgow Coma Scale indicating impaired consciousness)
  • Informed consent obtained from legal representatives

You may not qualify if:

  • Neuromuscular disease
  • Traumatic diaphragm injury
  • Thoracic deformity causing mechanical impairment of respiration
  • Terminal-stage patients
  • Patients in whom respiratory physiotherapy is contraindicated
  • Presence of a cardiac pacemaker or implantable cardioverter-defibrillator (ICD)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit University

Çorum, Centre, 19100, Turkey (Türkiye)

RECRUITING

Study Officials

  • Ozgur Yagan, MD

    Hitit University

    STUDY CHAIR

Central Study Contacts

Muhammed Talha Kiratli, MD

CONTACT

Selcuk Kayir, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start

August 1, 2025

Primary Completion

May 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

April 23, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations